AB0561 LONG-TERM PERSISTENCE OF ANTIPHOSPHOLIPID ANTIBODIES ANDASSESMENT RISK PROFILE IN WOMEN

Background

The evidence supporting the prognostic role of risk assessment in antiphospholipid antibodies (APA) positive patients has been obtained from several studies.

Objectives

to assess the association of the persistence of APA ≥ 12 weeks in women with an initial score on the aGAPSS scale, the presence of double and triple antibodies and a history of thrombosis or obstetric events.

Methods

A total of 117 women were included in the case-control study: 44 patients with persistence ≥ 1 antiphospholipid antibodies (APA) for 12 or more weeks (сases); 73 patients with transient circulation of APA less than 12 weeks (controls). An initial examination of women with a subsequent persistence of antiphospholipid antibodies ≥ 12 weeks compared with their transient circulation revealed.

Results

A higher incidence of arterial and venous thrombosis events, and a history of placenta-associated obstetric complications were observed in women with persistence of APA ≥ 12 weeks compared to transient circulation of APA, as well as a higher laboratory risk profile (double and triple positivity of APA. Overall, significantly higher aGAPSS were seen in women with persistence of APA ≥ 12 weeks compared to those with transient circulation of APA (7.37 ± 3.5 vs. 4.8 ± 0.6, p<0.05).

Conclusion

The aGAPSS scale is an additional tool available in clinical practice to clarify the risk profile in patients with APA-positivity in order to choose an adequate antithrombotic strategy. Future studies should evaluate the informativeness of the scale and determine cut-off points for predicting thrombosis and obstetric events.

Disclosure of Interests

None declared

THU0152 THE ADVANTAGES OF DISTANCE BLOOD PRESSURE MONITORING IN PATIENTS WITH RHEUMATOID ARTHRITIS

Background:

Cardiovascular complications are very common in patients with rheumatoid arthritis (RA). The monitoring of the course of RA and comorbid conditions is the key aspect of the prevention of early mortality.

Objectives:

To evaluate the effectiveness of the use of distance monitoring of blood pressure (BP) in patients with rheumatoid arthritis (RA) with comorbid arterial hypertension (AH).

Methods:

200 RA patients with AH (SBP – systolic 162.1 ± 7.3, DBP - diastolic 94.9 ± 9.2) are included in the trial, of which 8% are men. The average age was 54.0 ± 13.0. Patients were divided into 2 groups. Patients of group 1 (n=100) independently measured BP twice a day and entered the SBP and DBP results on self-control diaries in electronic form, or transmitted data from the tonometer via the installed mobile application. Pts of group 2 (n=100) were consulted on the first visit and in 3 months with further recommendations of monitoring and treatment of RA and AH.

Results:

Activity on DAS 28 (CRP), pain on VAS (mm), level of cholesterol, age and prednisolone use significant moderate correlated (p<0.01) with the level of SBP. In 6 months the average level of SBP and DBP were 131.4 ± 8.2 and 82.6 ± 5.1 mm Hg in group 1 respectively. In group 1 80% of pts achieved target BP in comparison with 50% of pts in group 2. The frequency of prescribing of two-component and three-component antihypertensive therapy increased in 1.8 and 1.9 times in 1 group; in 1.4 and 1.3 times respectively.

Conclusion:

Distance BP monitoring in patients with RA with the use of BP monitors with the function of remote data transmission lets to achieve target BP and hereby, reduce the incidence of adverse cardiovascular complications

Disclosure of Interests:

None declared